Keith Leonard

Keith R. Leonard is a distinguished biotechnology entrepreneur, investor, and philanthropist with a rich background in the healthcare and biopharmaceutical industry.

Currently serving as the Chairman of the Board at UNITY Biotechnology, he is known for his leadership in developing therapeutics that target diseases related to aging.

With an impressive career trajectory, Keith Leonard was previously the CEO of KYTHERA Biopharmaceuticals before its acquisition by Allergan, showcasing his expertise in navigating successful acquisitions.

His tenure at Amgen Inc., a global biotechnology leader, included key roles such as Senior Vice President and General Manager of Amgen Europe, where he oversaw commercial operations across 28 European countries.

Keith's diverse experience spans leadership positions in sales, marketing, engineering, operations, and finance, reflecting his versatile skill set in the industry.

Beyond his involvement with UNITY, Keith Leonard serves on the boards of renowned organizations like Intuitive Surgical and Sanifit S.A., illustrating his commitment to driving innovation in healthcare.

Apart from his corporate endeavors, Keith's philanthropic contributions are noteworthy, focusing on healthcare delivery, veteran's care, urban poverty, education, and environmental causes.

His educational background is equally impressive, holding degrees from prestigious institutions such as UCLA Anderson School of Management, University of California, Berkeley, and University of California, Los Angeles.

Keith's global exposure and professional journey have taken him to various countries, including Spain, Switzerland, Belgium, and the Netherlands, enriching his international perspective and business acumen.

As a former U.S. Navy officer and a leader in the biotechnology sector, Keith Leonard continues to make significant strides in advancing healthcare solutions and fostering social impact.